Research Progress of E3 Ubiquitin Ligase Adaptor Protein Keap1
Author:
Affiliation:

1)Department of Biochemistry and Molecular Biology, Medical School of Ningbo University, Ningbo 315211, China;2)Zhejiang Provincial Key Laboratory of Pathophysiology, Medical School of Ningbo University, Ningbo 315211, China

Clc Number:

Fund Project:

This work was supported by grants from the Core Courses of Medical School of Ningbo University, the Natural Science Foundation of Zhejiang Province (LY20C070001), Zhejiang Key Laboratory of Pathophysiology and Medical School of Ningbo University Joint Fund (201901), the Program of “Xinmiao” (Potenial) Talents in Zhejiang Province (2021R405043), the Student Research and Innovation Program of Ningbo University (2021SRIP1901, 2021SRIP1904), The National Natural Science Foundation of China (31801165) and the K.C. Wong Magna Fund in Ningbo University.

  • Article
  • |
  • Figures
  • |
  • Metrics
  • |
  • Reference
  • |
  • Related
  • |
  • Cited by
  • |
  • Materials
  • |
  • Comments
    Abstract:

    Kelch-like ECH associated protein 1(Keap1), a typical substrate-recognition subunit of the Cul-RING E3 ligase, plays a significant role in ubiquitination. Ubiquitination, an important post-translational modification, enables a degradation signal in both autophagy and ubiquitin-proteasome system. Recently, several substrates can be recognized and binded by wild-type Keap1, and subsequently degraded by ubiquitin proteasome system (UPS) via Keap1-Cul3-Rbx1 complex. Additionally, Keap1 has also been widely studied as a tumor suppressor protein, and mutation or abnormally deletion of Keap1 alleles contributes to different kinds of diseases. The study of Keap1 has mainly concentrated on the Keap1-Nrf2 axis, but rarely extends to downstream substrates. Given that the great importance of Keap1 in cells, this review summarizes the current research status of Keap1, including ubiquitin-proteasome system, Keap1’s structure and function, the mutation of Keap1, the substrates of Keap1, and Keap1-related diseases. It may provide a new thought for targeted therapy of Keap1-associated diseases through discussing the challenges of Keap1-related fields in clinic.

    Reference
    Related
    Cited by
Get Citation

NI Xiao-Qi, CHEN Xi-Wei, JIN Xiao-Feng. Research Progress of E3 Ubiquitin Ligase Adaptor Protein Keap1[J]. Progress in Biochemistry and Biophysics,2022,49(2):328-348

Copy
Share
Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
History
  • Received:January 18,2021
  • Revised:June 22,2021
  • Accepted:June 23,2021
  • Online: February 21,2022
  • Published: February 20,2022